Showing results (51-60 of 128) with videos related to
Sort By:
Pageof 13
Chest|December 12, 2007
Prognostic significance of thin-section CT scan findings in small-sized lung adenocarcinomaToshihiko Hashizume, Kouzo Yamada, Naoyuki Okamoto, et al.Case Reports in Gastroenterology|February 21, 2025
Steroid-Refractory Immune-Related Hepatitis Caused by Pembrolizumab with Stage IVB Non-Small Cell Lung Cancer: A Case ReportTomomi Hamaguchi, Makoto Ueno, Satoshi Kobayashi, et al.Lung Cancer (Amsterdam, Netherlands)|November 14, 2021
Effect of epidermal growth factor receptor gene mutation on the prognosis of pathological stage II-IIIA (8th edition TNM classification) primary lung cancer after curative surgeryTetsuya Isaka, Hiroyuki Ito, Haruhiko Nakayama, et al.Internal Medicine (Tokyo, Japan)|November 16, 2011
Severe obliterative bronchitis associated with Stevens-Johnson syndromeTetsukan Woo, Haruhiro Saito, Yasushi Yamakawa, et al.Oncology Reports|December 7, 2002
Expression of cyclin D1 but not of cyclin E is an indicator of poor prognosis in small adenocarcinomas of the lungMizuki Ikehara, Fumihiro Oshita, Hiroyuki Ito, et al.Lung Cancer (Amsterdam, Netherlands)|January 11, 2011
Alveolar space filling ratio as a favorable prognostic factor in small peripheral squamous cell carcinoma of the lungYukihiro Watanabe, Tomoyuki Yokose, Yuji Sakuma, et al.Thoracic Cancer|October 6, 2022
Comparison of next-generation sequencing and cobas EGFR mutation test v2 in detecting EGFR mutationsShuji Murakami, Tomoyuki Yokose, Kanako Shinada, et al.Oncology Reports|June 18, 2002
Expression of survivin correlated with vessel invasion is a marker of poor prognosis in small adenocarcinoma of the lungMizuki Ikehara, Fumihiro Oshita, Yoichi Kameda, et al.Journal of Cancer Research and Clinical Oncology|April 14, 2025
Comparison of programmed death ligand-1 expression in preoperative transbronchial lung biopsy and resected specimens in non-small cell lung cancerNaoko Shigeta, Shuji Murakami, Kouji Yamamoto, et al.Cancer Science|January 19, 2021
IMpower132: Atezolizumab plus platinum-based chemotherapy vs chemotherapy for advanced NSCLC in Japanese patientsMakoto Nishio, Haruhiro Saito, Koichi Goto, et al.Pageof 13